173 articles – 641 Notices  [english version]
HAL : hal-00396704, version 1

Fiche concise  Récupérer au format
Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable?
Girouin N., Mège-Lechevallier F., Tonina Senes A., Bissery A., Rabilloud M., Maréchal J.-M., Colombel M., Lyonnet D., Rouvière O.
European Radiology 17, 6 (2007) 1498-509 - http://hal.archives-ouvertes.fr/hal-00396704
Articles dans des revues avec comité de lecture
Sciences du Vivant/Ingénierie biomédicale
Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable?
Nicolas Girouin, Florence Mège-Lechevallier, Alejandro Tonina Senes, Alvine Bissery, Muriel Rabilloud 1, Jean-Marie Maréchal 2, Marc Colombel 3, Denis Lyonnet 4, Olivier Rouvière 5
1 :  Laboratoire de Biométrie et Biologie Evolutive (LBBE)
http://lbbe.univ-lyon1.fr/
Université Claude Bernard - Lyon I – CNRS : UMR5558 – INRIA
43 Bld du 11 Novembre 1918 69622 VILLEURBANNE CEDEX
France
2 :  Laboratoire des Mécanismes et Transfert en Géologie (LMTG)
http://www.lmtg.obs-mip.fr/
CNRS : UMR5563 – Observatoire Midi-Pyrénées – Université Paul Sabatier [UPS] - Toulouse III – Institut de recherche pour le développement [IRD] : UMR154
14 avenue Edouard Belin 31400 Toulouse
France
3 :  Service d'urologie [Lyon]
http://www.chu-lyon.fr/web/2681
Hospices Civils de Lyon – Hôpital Pierre-Bénite
5, place d'Arsonval, 69437 Lyon cedex 03
France
4 :  Hôpital Edouard Herriot
http://www.chu-lyon.fr/internet/chu/etablissements/heh/presentation_heh.htm
Hospices Civils de Lyon – Hôpital Edouard Herriot
5, place d'Arsonval - 69437 LYON cedex 03
France
5 :  Applications des ultrasons à la thérapie
http://www.lyon.inserm.fr/556/
INSERM : U556 – Université Claude Bernard - Lyon I
Centre de Recherche Inserm 151, Cours Albert Thomas 69424 LYON CEDEX 03
France
The purpose of this study was to evaluate the accuracy of prostate cancer localization with simple visual diagnostic criteria using dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI). A total of 46 consecutive patients with biopsy-proven prostate cancer underwent prostate 1.5 T MRI with pelvic phased-array coils before prostatectomy. Besides the usual T2-weighted sequences, a 30-s DCE sequence was acquired three times after gadoterate injection. On DCE images, all early enhancing lesions of the peripheral zone were considered malignant. In the central gland, only early enhancing lesions appearing homogeneous or invading the peripheral zone were considered malignant. Three readers specified the presence of cancer in 20 prostate sectors and the location of distinct tumors. Results were compared with histology; p < 0.05 was considered significant. For localization of cancer in the sectors, DCE imaging had a significantly higher sensitivity [logistic regression, odds ratio (OR): 3.9, p < 0.0001] and a slightly but significantly lower specificity (OR: 0.57, p < 0.0001). Of the tumors >0.3 cc, 50-60% and 78-81% were correctly depicted with T2-weighted and DCE imaging, respectively. For both techniques, the depiction rate of tumors >0.3 cc was significantly influenced by the Gleason score (most Gleason
Anglais

European Radiology (Eur Radiol)
Publisher Springer Verlag (Germany)
ISSN 0938-7994 (eISSN : 1432-1084)
internationale
06/2007
28/11/2006
17
6
1498-509

Aged – Biopsy – Contrast Media – Heterocyclic Compounds – Humans – Image Processing – Computer-Assisted – Logistic Models – Magnetic Resonance Imaging – Male – Middle Aged – Organometallic Compounds – Prostatectomy – Prostatic Neoplasms – Sensitivity and Specificity